Pfizer, Mylan Push To Pare Down EpiPen Class Action

By Kevin Stawicki (July 16, 2020, 8:26 PM EDT) -- EpiPen manufacturer Pfizer and distributor Mylan asked a Kansas federal judge to pare down remaining claims in multidistrict litigation over the price of the emergency allergy treatment, saying EpiPen buyers failed to show how the companies conspired to delay the entry of generic competitors....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!